Compositions containing therapeutically active components having enhanced solubility

Details for Australian Patent Application No. 2005234735 (hide)

Owner Allergan, Inc.

Inventors Not Given

Agent Davies Collison Cave

Pub. Number AU-A-2005234735

Parent 2001273268

Filing date 22 November 2005

Wipo publication date 8 December 2005

International Classifications

A61K 031/557 - Eicosanoids, e.g. leukotrienes

A61K 009/08 Medicinal preparations characterised by special physical form - Solutions

A61K 047/02 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 047/38 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

8 December 2005 Application Open to Public Inspection

  Published as AU-A-2005234735

8 December 2005 Complete Application Filed

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005234736-Terminal cluster block

2005234734-Sampling device to assemble tissue array